Back to top
Prof Lars Erik Kristensen

Prof Lars Erik Kristensen

Head of Research

Professor Lars Erik Kristensen is Head of Research at the Parker Institute in Copenhagen, Denmark, and holds an honorary doctoral position at Lund University, Sweden, and a professorship at Copenhagen University, Denmark. He received his medical degree from Copenhagen University and a PhD in Clinical Medicine from Lund University. He later specialised in internal medicine and rheumatology. Professor Kristensen also completed a postdoc at Karolinska University, Sweden.

 

Professor Kristensen’s research interests are degenerative and inflammatory arthritis, with a focus on patient value, lifestyle factors, treatment response and predictors thereof in randomised controlled trials and observational settings. He also managed his own research group (South Swedish Arthritis Treatment Group [SSATG]) in Lund from 2011 to 2013. Professor Kristensen is also a board member and head of research at the Danish Society of Rheumatology. He has given >250 lectures at national and international congresses and meetings.

0 resources
You are currently seeing only Dermatology content
Image
Video_15_03.31.png
Video41:11 min
Navigating the new European S2k guidelines for hidradenitis suppurativa: How will they change your clinical practice?

Unlock the European S2k HS guidelines. Prof. Tzellos and Prof. Bechara share expert insights and implications of the updated guidelines

EU-BK-2500021
Image
Video_14_02.02.png
Video6:55 min
Setting up MDT care in HS: Learning from psoriasis

Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare

EU-DA-2400507
Image
250715_Use of imaging in HS management_thumbnail Med Hub.png
Video6:30 min
Use of imaging in HS management

Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation

EU-DA-2400506
Image
Video_12_1.51.png
Video4:25 min
Evidence-based approach to medical management based on the European guidelines for HS

Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy

EU-BK-2400332